Astellas appoints VP, global medicine safety
This article was originally published in Scrip
Astellas Pharma Global Development – a subsidiary of Astellas Pharma Inc, based in Tokyo, Japan – has appointed Robin J McGarry vice-president, global medicine safety head. For the past 13 years Ms McGarry worked as an independent consultant, providing pharmacovigilance, clinical, and regulatory strategic consulting services. And in the past she was vice-president of worldwide safety at Pfizer. Furthermore, Astellas Pharma Global Development has promoted Mark Weinberg to vice-president of Global Clinical Science at the company. Mr Weinberg joined Astellas in 2011 as global therapeutic area head in CNS and pain.